COVID- 19患者治疗过程中常用药物副作用研究进展

Parisa Saberi Hasanabadi, R. Ataee
{"title":"COVID- 19患者治疗过程中常用药物副作用研究进展","authors":"Parisa Saberi Hasanabadi, R. Ataee","doi":"10.18502/pbr.v7i4.9371","DOIUrl":null,"url":null,"abstract":"Background: Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To increase the success in treating patients with COVID-19, many drug suggestions and some clinical studies are shared in the literature. However, the combination of several drugs with other clinical care has improved patients' conditions. And this review discusses some side effects of Covid-19 drugs' adverse effects. \nObjectives: Here, we have shortly reported the recent updates on the most common and plausible drugs for treating COVID-19 patients. We also compare these treatment options based on their impact on symptom management, inpatient length of stay, and overall morbidity and mortality. \nMethods: An extensive literature search was performed through PubMed, Scopus, Web of Science, and Google Scholar. Most of the keywords used were: \"COVID-19\", \"Side effects of used drugs,\" \"Treatment of COVID-19\", \"Risk factors,\" \"Organ damage,\" and \"Methods of diagnosis and treatment.\" \nResults: Anti-inflammatory, antimicrobial, and vitamin supplements do not have obvious benefits, but there is limited information to consider. Other factors and drugs such as improved plasma, eculizumab, immunoglobulins, IgG1-neutralizing monoclonal antibodies, remidseiver, steroids, and tosilizumab have shown potential effects on patient's length of hospital stay and mortality. Currently, there is no evidence that any other vaccines, apart from those specifically designed for the SARSCov-2 virus, will protect against COVID-19. \nConclusion: Since the prevention of the COVID-19 virus is a new issue in the medical world, there is no known effective treatment option in this area, and the prevention of its adverse side effects has not been conclusively proven. Of course, the occurrence of side effects in patients undergoing treatment such as hepatotoxicity, retinal damage, nephrotoxicity, and cardiotoxicity proves that the necessary caution should be used in drug combination methods.","PeriodicalId":6323,"journal":{"name":"2005 Asian Conference on Sensors and the International Conference on New Techniques in Pharmaceutical and Biomedical Research","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Review on Current Side Effects of Used Drugs During Treatment of Patients With COVID- 19\",\"authors\":\"Parisa Saberi Hasanabadi, R. Ataee\",\"doi\":\"10.18502/pbr.v7i4.9371\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To increase the success in treating patients with COVID-19, many drug suggestions and some clinical studies are shared in the literature. However, the combination of several drugs with other clinical care has improved patients' conditions. And this review discusses some side effects of Covid-19 drugs' adverse effects. \\nObjectives: Here, we have shortly reported the recent updates on the most common and plausible drugs for treating COVID-19 patients. We also compare these treatment options based on their impact on symptom management, inpatient length of stay, and overall morbidity and mortality. \\nMethods: An extensive literature search was performed through PubMed, Scopus, Web of Science, and Google Scholar. Most of the keywords used were: \\\"COVID-19\\\", \\\"Side effects of used drugs,\\\" \\\"Treatment of COVID-19\\\", \\\"Risk factors,\\\" \\\"Organ damage,\\\" and \\\"Methods of diagnosis and treatment.\\\" \\nResults: Anti-inflammatory, antimicrobial, and vitamin supplements do not have obvious benefits, but there is limited information to consider. Other factors and drugs such as improved plasma, eculizumab, immunoglobulins, IgG1-neutralizing monoclonal antibodies, remidseiver, steroids, and tosilizumab have shown potential effects on patient's length of hospital stay and mortality. Currently, there is no evidence that any other vaccines, apart from those specifically designed for the SARSCov-2 virus, will protect against COVID-19. \\nConclusion: Since the prevention of the COVID-19 virus is a new issue in the medical world, there is no known effective treatment option in this area, and the prevention of its adverse side effects has not been conclusively proven. Of course, the occurrence of side effects in patients undergoing treatment such as hepatotoxicity, retinal damage, nephrotoxicity, and cardiotoxicity proves that the necessary caution should be used in drug combination methods.\",\"PeriodicalId\":6323,\"journal\":{\"name\":\"2005 Asian Conference on Sensors and the International Conference on New Techniques in Pharmaceutical and Biomedical Research\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2005 Asian Conference on Sensors and the International Conference on New Techniques in Pharmaceutical and Biomedical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/pbr.v7i4.9371\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2005 Asian Conference on Sensors and the International Conference on New Techniques in Pharmaceutical and Biomedical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/pbr.v7i4.9371","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:冠状病毒病2019 (COVID-19)是由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)引起的传染性疾病。为了提高COVID-19患者的治疗成功率,文献中分享了许多药物建议和一些临床研究。然而,几种药物与其他临床护理的结合改善了患者的病情。本文就新冠肺炎药物的一些副作用进行了综述。目的:在这里,我们简要报告了治疗COVID-19患者最常见和最合理的药物的最新进展。我们还比较了这些治疗方案对症状管理、住院时间和总体发病率和死亡率的影响。方法:通过PubMed、Scopus、Web of Science和Google Scholar进行广泛的文献检索。使用最多的关键词是:“COVID-19”、“使用药物的副作用”、“COVID-19的治疗”、“危险因素”、“器官损害”和“诊断和治疗方法”。结果:抗炎、抗菌和维生素补充剂没有明显的益处,但可供考虑的信息有限。其他因素和药物,如改善血浆、eculizumab、免疫球蛋白、igg1中和单克隆抗体、remidsever、类固醇和tosilizumab,已显示出对患者住院时间和死亡率的潜在影响。目前,没有证据表明,除了专门为SARSCov-2病毒设计的疫苗外,还有任何其他疫苗可以预防COVID-19。结论:COVID-19病毒的预防是医学界的一个新课题,目前尚无已知的有效治疗方案,其不良反应的预防尚未得到最终证实。当然,在接受治疗的患者中出现肝毒性、视网膜损伤、肾毒性、心脏毒性等副作用,证明在联合用药方法中应谨慎使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Review on Current Side Effects of Used Drugs During Treatment of Patients With COVID- 19
Background: Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To increase the success in treating patients with COVID-19, many drug suggestions and some clinical studies are shared in the literature. However, the combination of several drugs with other clinical care has improved patients' conditions. And this review discusses some side effects of Covid-19 drugs' adverse effects. Objectives: Here, we have shortly reported the recent updates on the most common and plausible drugs for treating COVID-19 patients. We also compare these treatment options based on their impact on symptom management, inpatient length of stay, and overall morbidity and mortality. Methods: An extensive literature search was performed through PubMed, Scopus, Web of Science, and Google Scholar. Most of the keywords used were: "COVID-19", "Side effects of used drugs," "Treatment of COVID-19", "Risk factors," "Organ damage," and "Methods of diagnosis and treatment." Results: Anti-inflammatory, antimicrobial, and vitamin supplements do not have obvious benefits, but there is limited information to consider. Other factors and drugs such as improved plasma, eculizumab, immunoglobulins, IgG1-neutralizing monoclonal antibodies, remidseiver, steroids, and tosilizumab have shown potential effects on patient's length of hospital stay and mortality. Currently, there is no evidence that any other vaccines, apart from those specifically designed for the SARSCov-2 virus, will protect against COVID-19. Conclusion: Since the prevention of the COVID-19 virus is a new issue in the medical world, there is no known effective treatment option in this area, and the prevention of its adverse side effects has not been conclusively proven. Of course, the occurrence of side effects in patients undergoing treatment such as hepatotoxicity, retinal damage, nephrotoxicity, and cardiotoxicity proves that the necessary caution should be used in drug combination methods.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信